INDIVIDUAL PEPTIDES
Acetyl Decapeptide-3 is a cosmetic peptide candidate for texture, age-care and tone-development briefs. Review the ten-residue identity and distinguish peptide research from growth-factor claims before requesting current documents, an evaluation sample or a quotation.
On this page Overview Identity Review Questions Enquire →
- Catalogue reference
- KI-020
- Product family
- Individual peptides
- CAS reference
- 935288-50-9
- Public INCI identity reference
- Acetyl Decapeptide-3
The public overview identifies the catalogue material. Confirm the supplied grade, full composition and current batch specifications in the supplier documents.
Development directions
Texture, age-care and even-looking-tone concepts should be evaluated as separate cosmetic endpoints. The supplier catalogue discusses a biomimetic rationale; it does not supply matched clinical evidence for the exact material currently offered.
Possible formulation formats
- Facial texture-care serum evaluation
- Age-care cosmetic emulsion
- Even-looking-tone formula screening
Formulation concepts for evaluation. Review the actual supplied material and finished formula for the intended cosmetic use.
Identity and supplied form
The CAS 935288-50-9 reference describes Ac-YRSRKYTSWY-NH2: an acetylated ten-residue peptide with a C-terminal amide. Confirm sequence, counterions, peptide content and complete preparation identity against the offered-material documents.
A biomimetic peptide is not a recombinant growth factor
The public record identifies a short synthetic peptide. A supplier’s growth-factor-mimetic description does not make this material recombinant FGF or EGF, or establish tissue regeneration in a finished cosmetic. Assess the actual experimental preparation, model and endpoint before using such a mechanism in a product brief.
Compare the material for your brief
Compare this acetylated decapeptide with other sequence-defined peptides on identity, content and formulation fit. A product sold under a preparation trade name may include solvents and preservatives; neither its formulation percentage nor its performance transfers automatically to another supplied form.
Formulation review priorities
| Review point | What to establish |
|---|---|
| Peptide structure | Match all ten residues and both terminal modifications to the current identity statement. |
| Claim selection | Choose texture, tone appearance or another defined cosmetic endpoint rather than an undefined growth-factor claim. |
| Preparation fit | Compare full composition and supplied-form guidance in the intended serum or emulsion. |
Public reference sources
PubChem: Acetyl Decapeptide-3 identity →
GENOPEP: public catalogue reference →
Reference review: 31 October 2026. These public sources describe identity, research or third-party preparations. Confirm the exact offered material and its current documents for your project.
Questions for your brief
- Which texture, tone or age-care endpoint is your priority?
- What identity and supplied-form documents do you require?
- What sample quantity, market and destination should we review?
Is Acetyl Decapeptide-3 a recombinant growth factor?
No. The public chemical reference describes a defined short peptide. A biomimetic development rationale does not establish equivalence to a recombinant growth factor.
Can the same ingredient support several cosmetic claims?
Each proposed claim needs a relevant endpoint and formula assessment. A multi-benefit description does not establish the size or timing of results in your product.